دورية
Associations between the activity of placental nutrient-sensing pathways and neonatal and postnatal metabolic health: the ECHO Healthy Start cohort
| العنوان: | Associations between the activity of placental nutrient-sensing pathways and neonatal and postnatal metabolic health: the ECHO Healthy Start cohort |
|---|---|
| المؤلفون: | Keleher, Madeline Rose, Erickson, Kathryn, Kechris, Katerina, Yang, Ivana V., Dabelea, Dana, Friedman, Jacob E., Boyle, Kristen E., Jansson, Thomas |
| المصدر: | International Journal of Obesity (formerly International Journal of Obesity and Related Metabolic Disorders); November 2020, Vol. 44 Issue: 11 p2203-2212, 10p |
| مستخلص: | Objective: Our hypothesis was that the activity of placental nutrient-sensing pathways is associated with adiposity and metabolic health in childhood. Research design and methods: Using placental villus samples from healthy mothers from the Healthy Start Study, we measured the abundance and phosphorylation of key intermediates in the mTOR, insulin, AMPK, and ER stress signaling pathways. Using multivariate multiple regression models, we tested the association between placental proteins and offspring adiposity (%fat mass) at birth (n= 109), 4–6 months (n= 104), and 4–6 years old (n= 64), adjusted for offspring sex and age. Results: Placental mTORC1 phosphorylation was positively associated with adiposity at birth (R2= 0.13, P= 0.009) and 4–6 years (R2= 0.15, P= 0.046). The mTORC2 target PKCα was positively associated with systolic blood pressure at 4–6 years (β = 2.90, P= 0.005). AMPK phosphorylation was positively associated with adiposity at birth (β = 2.32, P= 0.023), but the ratio of phosphorylated to total AMPK was negatively associated with skinfold thickness (β = −2.37, P= 0.022) and body weight (β = −2.92, P= 0.005) at 4–6 years. Conclusions: This is the first report of associations between key placental protein activity measures and longitudinal child outcomes at various life stages. Our data indicate that AMPK and mTOR signaling are linked to cardiometabolic measures at birth and 4–6 years, providing novel insight into potential mechanisms underpinning how metabolic signaling in the placenta is associated with future risk of cardiovascular disease. |
| قاعدة البيانات: | Supplemental Index |
| تدمد: | 03070565 14765497 |
|---|---|
| DOI: | 10.1038/s41366-020-0574-y |